Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

RESOLUTE-III All-comers Trial: A Randomized Comparison of a Zotarolimus-Eluting Stent With an Everolimus-Eluting Stent for Percutaneous Coronary Intervention

NCT00617084 is registered in ClinicalTrials.gov with Medtronic Vascular as lead sponsor.

NCT NCT00617084
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00617084 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
RESOLUTE-III All-comers Trial: A Randomized Comparison of a Zotarolimus-Eluting Stent With an Everolimus-Eluting Stent for Percutaneous Coronary Intervention
Lead sponsor
Medtronic Vascular
Phase
Phase 4
Overall status
Completed
Start date
April 30, 2008
Completion date
February 28, 2014
Enrollment
2,292 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

coronary artery disease